Home
Conditions
Hodgkin Disease

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies

Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT00262860

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States

James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

NCT01904175

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Quality of Life Among Survivors of Hodgkin Lymphoma

NCT00598728

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

NCT00293384

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +112 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

NCT00618969

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +26 more
Locations: Arizona Cancer Center/University Medical Center Tucson, Arizona, United States

View Trial Details

Completed

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

NCT01413568

Conditions: Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Blood Protein Disorders, +36 more
Locations: University of Kansas Cancer Center Kansas City, Kansas, United States

Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

NCT00975975

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma

NCT01195766

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Hospital Sant Pau Barcelona, Spain

Hospital Clinic Barcelona, Spain

Instituto Catalan de Oncologia L'Hospitalet de Llobregat, Barcelona, Spain

View all 14 locations

View Trial Details

Completed

Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors

NCT02150148

Conditions: Behavior, Breast Diseases, Breast Neoplasms, +50 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

NCT00648037

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Hodgkin Disease

Hodgkin Disease trial results

Related conditions